DITPA stimulates bFGF, VEGF, angiopoietin, and Tie-2 and facilitates coronary arteriolar growth

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 284, Issue 2 53-2, 2003, Pages

  Wang, Xinguo ^a   Zheng, Wei ^a   Christensen, Lance P ^a   Tomanek, Robert J ^a,b  

^a UNIVERSITY OF IOWA   (United States)

^b UNIVERSITY OF IOWA   (United States)

Author keywords

3,5 diiodothyroproprionic acid; Angiogenesis; Basic fibroblast growth factor; Growth factors; Vascular endothelial growth factor

Indexed keywords

3,5 DIIODOTHYROPROPIONIC ACID; ANGIOPOIETIN; ANGIOPOIETIN RECEPTOR; BASIC FIBROBLAST GROWTH FACTOR; PROPIONIC ACID DERIVATIVE; RECEPTOR PROTEIN; THYROXINE; UNCLASSIFIED DRUG; VASCULOTROPIN;

ANGIOGENESIS; ANIMAL EXPERIMENT; ARTERIOLE; ARTICLE; BLOOD VESSEL DIAMETER; CHRONOTROPISM; CONTROLLED STUDY; CORONARY BLOOD VESSEL; HEART INFARCTION; HEART LEFT VENTRICLE FUNCTION; IMAGE ANALYSIS; INOTROPISM; MALE; NONHUMAN; PRIORITY JOURNAL; RAT;

EID: 0037306771     PISSN: 03636135     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpheart.00449.2002     Document Type: Article

References (33)

1. Breisch EA, White FD, Hammond HK, Flynn S, and Bloor CM. Myocardial characteristics of thyroxine stimulated hypertrophy: a structural and functional study. Basic Res Cardiol 84: 345-358, 1989.
2. Chen Y, Torry RJ, Baumbach GL, and Tomanek RJ. Proportional arteriolar growth accompanies cardiac hypertrophy induced by volume overload. Am J Physiol Heart Circ Physiol 267: H2132-H2137, 1994.
3. Chilian WM, Wangler RD, Peters KG, Tomanek RJ, and Marcus ML. Thyroxine-induced left ventricular hypertrophy in the rat: anatomical and physiological evidence for angiogenesis. Circ Res 57: 591-598, 1985.
4. Hangai M, Murata T, Miyawaki N, Spee C, Lim JI, He S, Hinton DR, and Ryan SJ. Angiopoietin-1 upregulation by vascular endothelial growth factor in human retinal pigment epithelial cells. Invest Ophthalmol Vis Sci 42: 1617-1625, 2001.
5. Harrison DG, Marcus ML, Dellsperger KC, Lamping KL, and Tomanek RJ. Pathophysiology of myocardial perfusion in hypertension. Circulation 83, Suppl III: III-14-III-18, 1991.
6. Hayes AJ, Huang WQ, Mallah J, Yang D, Lippman ME, and Li LY. Angiopoietin-1 and its receptor Tie-2 participate in the regulation of capillary-like tubule formation and survival of endothelial cells. Microvasc Res 58: 224-237, 1999.
7. Heron MI, Kolar F, Papousek F, and Rakusan K. Early and late effect of neonatal hypo- and hyperthyroidism on coronary capillary geometry and long-term heart function in rat. Cardiovasc Res 33: 230-240, 1997.
8. Hoit BD, Pawloski-Dahm CM, Shao Y, Gabel M, and Walsh RA. The effects of a thyroid hormone analog on left ventricular performance and contractile and calcium cycling proteins in the baboon. Proc Assoc Am Physicians 109: 136-143, 1997.
9. Hughes SE and Hall PA. Overview of the fibroblast growth factor and receptor families: complexity, functional diversity, and implications for future cardiovascular research. Cardiovasc Res 27: 1199-1203, 1993.
10. Kliche S and Waltenberger J. VEGF receptor signaling and endothelial function. IUBMB Life 52: 61-66, 2001.
11. Lazarous DF, Shon M, Scheinowitz M, Hodge E, Thirumurti V, Kitsion AN, Stiber JA, Lobo AD, Humsberger S, Guetta E, Epstein SE, and Unger EF. Comparative effects of basic fibroblast growth factor and vascular endothelial growth factor on coronary collateral development in the arterial response to injury. Circulation 94: 1074-1082, 1996.
12. Litwin SE, Zhang D, Roberge P, and Pennock CD. DITPA prevents the blunted contraction-frequency relationship in myocytes from infarcted hearts. Am J Physiol Heart Circ Physiol 278: H862-H870, 2000.
13. Mahaffey KW, Raya TE, Pennock GD, Morkin E, and Goldman S. Left ventricular performance and remodeling in rabbits after myocardial infarction: effects of a thyroid hormone analogue. Circulation 91: 794-801, 1995.
14. Mall G, Zimmer G, Baden S, and Mattfeldt T. Capillary neoformation in the rat heart: stereological studies on papillary muscle in hypertrophy and physiologic growth. Basic Res Cardiol 85: 531-540, 1990.
15. Pennock GD, Raya TE, Bahl JJ, Goldman S, and Morkin E. Cardiac effects of 3,5-diiodothyropropionic acid, a thyroid analog with inotropic selectivity. J Pharmacol Exp Ther 263: 163-169, 1992.
16. Pennock GD, Raya TE, Bahl JJ, Goldman S, and Morkin E. Combination treatment with captopril and the thyroid hormone analogue 3,5-diiodothyropropionic acid. Circulation 88: 1289-1298, 1993.
17. Pennock GD, Spooner PH, Summers CE, and Litwin SE. Prevention of abnormal sarcoplasmic reticulum calcium transport and protein expression in post-infarction heart failure using 3,5-diiodothyropropionic acid (DITPA). J Mol Cell Cardiol 32: 1939-1953, 2000.
18. Rajanayagam MA, Shon M, Thirumurti V, Lazarous DF, Guyyumi AA, Goncalves L, Stiber J, Epstein SE, and Unger EF. Intracoronary basic fibroblast growth factor enhances myocardial collateral perfusion in dogs. J Am Coll Cardiol 35: 519-526, 2000.
19. Reidy MA and Lindner V. Basic FGF and growth of arterial cells. Ann NY Acad Sci 638: 290-299, 1991.
20. Singh TM, Abe KY, Sasaki T, Zhuang YJ, Masuda H, and Zarins CK. Basic fibroblast growth factor expression precedes flow-induced arterial enlargement. J Surg Res 77: 165-173, 1998.
21. Spooner PH, Morkin E, and Goldman S. Thyroid hormone and thyroid hormone analogues in the treatment of heart failure. Coron Artery Dis 10: 395-399, 1999.
22. Sundberg C, Kowanetz M, Brown LF, Detmar M, and Dvorak HF. Stable expression of angiopoietin-1 and other markers by cultured pericytes: phenotypic similarities to a subpopulation of cells in maturing vessels during alter stages of angiogenesis in vivo. Lab Invest 82: 387-401, 2002.
23. Tomanek RJ, Aydelotte MR, and Torry RJ. Remodeling of coronary vessels during aging in purebred beagles. Circ Res 69: 1068-1074, 1991.
24. Tomanek RJ and Busch TL. Coordinated capillary and myocardial growth in response to thyroxine treatment. Anat Rec 251: 44-49, 1998.
25. Tomanek RJ, Connel PM, Butters CA, and Torry RJ. Compensated coronary microvascular growth in senescent rats with thyroxine-induced cardiac hypertrophy. Am J Physiol Heart Circ Physiol 268: H419-H425, 1995.
26. Tomanek RJ, Doty MK, and Sandra A. Early coronary angiogenesis in response to thyroxine: growth characteristics and upregulation of basic fibroblast growth factor. Circ Res 82: 587-593, 1998.
27. Tomanek RJ, Sandra A, Zheng W, Brock T, Bjereke RJ, and Holifield JS. Vascular endothelial growth factor and basic fibroblast growth factor differentially modulate early postnatal coronary angiogenesis. Circ Res 88: 1135-1141, 2001.
28. Tomanek RJ and Torry RJ. Growth of the coronary vasculature in hypertrophy: mechanisms and model dependence. Cell Mol Biol Res 40: 129-136, 1994.
29. Tomanek RJ, Zimmerman MB, Suvarna PR, Morkin E, Pennock GD, and Goldman S. A thyroid hormone analog stimulates angiogenesis in the post-infarcted rat heart. J Mol Cell Cardiol 30: 923-932, 1998.
30. Wachtlova M, Ostadal B, and Mares V. Thyroxine-induced cardiomegaly in rats of different age. Physiol Bohemoslou 34: 385-395, 1985.
31. to in rats after myocardial infarction. Am J Physiol Heart Circ Physiol 278: H1105-H1116, 2000.
32. Zheng W, Brown MD, Brock TA, Bjercke RJ, and Tomanek RJ. Bradycardia-induced coronary angiogenesis is dependent on vascular endothelial growth factor. Circ Res 85: 192-198, 1999.
33. Zheng W, Seftor EA, Meininger CY, Hendrix MJC, and Tomanek RJ. Mechanisms of coronary angiogenesis in response to stretch: role of VEGF and TGF-β. Am J Physiol Heart Circ Physiol 280: H909-H917, 2001.